InsideArbitrage Potential Deal Alert: Rain Oncology (RAIN) approached by Concentra for $1.25 per share
October 15, 2023
According to an amended 13D filing, Rain Oncology (RAIN) received an acquisition proposal from Concentra Biosciences, an affiliate of Tang Capital Partners, for $1.25 per share in cash.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
